Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin for hospitalized adults with COVID-19
IRCT20200329046892N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin + standard care with Placebo + standard care (2 arms). Primary endpoint: Time required to improve clinical symptoms and paraclinical measures. Started Apr 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200329046892N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200329046892N3.